← Back to Search

Intervention Group for Coronary Artery Disease

N/A

Waitlist Available

Led By Stephen B Wilton, MD, MSc

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age at least 40 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months).

Awards & highlights

Study Summary

This trial is testing a new online tool to measure & report quality of life & health status of patients with heart disease, to help physicians better manage their symptoms.

Who is the study for?

This trial is for adults over 40 with known or suspected coronary artery disease, who can communicate in English (or have help) and have internet access. They must be seeing a participating cardiologist soon.Check my eligibility

What is being tested?

The study tests an electronic system where patients report their health status online, which then gets shared with their doctors to improve care for heart conditions.See study design

What are the potential side effects?

Since this trial involves completing surveys rather than taking medication, there are no direct medical side effects. However, participants may experience inconvenience or privacy concerns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months).

This trial's timeline: 3 weeks for screening, Varies for treatment, and patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability and utility of the ePROM Patient Survey and Clinician Report to patients

Acceptability of the Clinician Report to clinicians

ePROM usage metrics

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Patients in this group will complete the ePROM patient survey in advance of their care visit.

Group II: Control GroupActive Control1 Intervention

Patients in this group will attend their cardiology appointment as normal. No intervention present.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,345 Previous Clinical Trials

26,453,314 Total Patients Enrolled

25 Trials studying Coronary Artery Disease

29,278 Patients Enrolled for Coronary Artery Disease

University of CalgaryLead Sponsor

792 Previous Clinical Trials

868,954 Total Patients Enrolled

11 Trials studying Coronary Artery Disease

10,596 Patients Enrolled for Coronary Artery Disease

Stephen B Wilton, MD, MScPrincipal InvestigatorAPPROACH Research Group, Libin Cardiovascular Institute, Cumming School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still recruiting participants for this clinical trial?

"As per clinicaltrials.gov, this particular research project is no longer seeking participants after being initially posted on January 1st 2024 and last updated December 8th 2023. Despite this trial ceasing its recruitment efforts, there are currently 583 other medical studies actively registering patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease

2024. "Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06164457.

All > Coronary Artery Disease